Ben Lake

We have no such plans.

I have interpreted your question to refer to health professionals (HPs) who conduct Personal Independence Payment (PIP) assessments and Work Capability Assessments (WCA) for our assessment suppliers on behalf of the department, and not Department for Work and Pensions decision makers who make decisions on entitlement to benefit.

The Functional Assessment Service contracts require assessment suppliers to act in a manner supportive of the Armed Forces Covenant, to ensure the fair treatment of veterans and their families.

PIP assessments and WCAs are not medical consultations and do not require HPs to diagnose conditions or recommend treatment. Instead, they are functional assessments designed to evaluate how an individual’s health conditions or impairments affect their ability to carry out daily living activities and/or their capability for work.

HPs conducting assessments are trained specialists in disability analysis. Their focus is on understanding the functional impact of a claimant’s condition, rather than its clinical diagnosis. All HPs receive specific training on assessing the effects of mental health conditions and are supported by Mental Health Function Champions (MHFCs). MHFCs are experienced professionals with relevant expertise in mental health, cognitive, developmental, and learning disabilities. They are available to provide advice and support throughout the assessment process.

Additionally, HPs have access to Condition Insight Reports and Continuing Professional Development (CPD) guides. These resources offer detailed clinical and functional information on a range of conditions, including Post-Traumatic Stress Disorder, to support HPs in delivering informed assessments.

Furthermore, within the WCA core training and guidance material (CTGM) there is a CPD module titled ‘life post miliary service’. While this does not currently form part of the PIP CTGM, we do intend to make this available across the benefit strands.

On 25 June, I attended an online event with veterans, as one of the series of consultation events on the proposals in the Pathways to Work Green Paper.

Currently, Work Capability Assessment re-assessments are prioritised for customers on Employment and Support Allowance and the health element of Universal Credit who report a change in their health condition. Routine department-led reassessments are scheduled according to expected prognosis length for recovery and subject to available assessment capacity.

Individuals who have Limited Capability for Work- and Work-Related Activity (LCWRA), with the most severe and lifelong health conditions or disabilities, whose level of function means that they will always have LCWRA and are unlikely ever to be able to move into work, are not routinely reassessed.

Our wide-ranging package of reforms to health and disability benefits, set out in the Pathways to Work Green Paper, will improve experiences of the system for those who need it. The functional impact and severity of a condition can significantly vary across individuals, which is why we will continue to ensure that those with the most severe, life-long health conditions, who will never be able to work, will not need to be reassessed.

As part of our commitment to hear from members of the public directly, including disabled people and their representatives, we have now held a number of virtual and in person public consultation events, as per the advertised schedule on GOV.UK.

Unfortunately, the Cardiff in person event was postponed from 3 June to 23 June, due to the venue cancelling last minute. We have worked with the Welsh Government to rearrange this event and have reached out to all registered participants directly, including registered members of the public and registered representatives from Welsh charities and other organisations, to rebook their place on a re-scheduled Cardiff event, also offering a priority space on other virtual events. A Wales-only virtual consultation event has now also been arranged and scheduled for 26 June.

Throughout the consultation we are committed to putting the views and voices of disabled people and people with health conditions at the heart of everything we do. We encourage members of the public, including disabled people’s organisations in Wales, to continue to respond to the consultation online, in writing and via email until the deadline on 30 June.

In the meantime, DWP Ministers continue to engage with individuals and groups in Wales. On 22 April, the Minister for Employment visited Denbighshire in North Wales to announce the launch of the Inactivity Trailblazer, as part of wider efforts to tackle inactivity - with funding from the £125m (in for 2025/26) announced in the Get Britain Working White Paper being designated to this area. The Minister for Employment also visited Mold Jobcentre during this visit to Wales.

Information on the impacts of the Pathways to Work Green Paper will be published in due course, and some information was published alongside the Spring Statement. These publications can be found in ‘Pathways to Work: Reforming Benefits and Support to Get Britain Working Green Paper’.

A further programme of analysis to support development of the proposals in the Green Paper will be developed and undertaken in the coming months.

Everyone who has been harmed following use of anti-seizure medication has our deepest sympathies. We fully understand the importance of patient safety, which is a top priority for this government. It is vital we do all we can to stop harm from happening in the first place.

The Medicines and Healthcare products Regulatory Agency rigorously monitors and reviews all emerging data and risks in relation to anti-seizure medication and communicates information on risks to patients. Following Baroness Cumberlege’s 2020 Independent Medicines and Medical Devices Safety (IMMDS) Review, which examined the anti-seizure medication Sodium Valproate in detail, several actions have been taken to ensure that valproate is only prescribed when clinically appropriate. These include ensuring valproate is not started in new patients younger than 55 years old unless two specialists independently consider and document that there is no other effective or tolerated treatment, or there are compelling reasons that the reproductive risks do not apply.

One of the conclusions of the IMMDS Review was that a public inquiry would not best serve the interests of those affected by each of the interventions covered by the review. We have no plans to launch a public inquiry into the potential harms of anti-seizure medication.

On 28 February 2025, further to engagement with industry representative bodies, the Food Standards Agency published the 2025/26 charge rates for inspections in meat premises in England and Wales. As in previous years, charges in 2025/26 will be offset by a taxpayer-funded discount scheme which will provide the greatest proportional support to smaller abattoirs, and will therefore benefit the small abattoir industry in Wales. A separate exercise is being conducted in respect of 2025/26 charges for abattoirs in Northern Ireland.

The 10-Year Health Plan will deliver the three big shifts the National Health Service needs to be fit for the future: from hospital to community, from analogue to digital, and from sickness to prevention. All of these are relevant to improving cardiac health in all parts of the country.

More tests and scans delivered in the community, better joint working between services, and greater use of apps and wearable technology will all help people manage their long-term conditions, including cardiac disease, closer to home. Moving from sickness to prevention will help us provide treatment earlier, rather than only intervening when conditions deteriorate.

NHS England has published a national service specification for inherited cardiac conditions that covers patients who often present as young adults with previously undiagnosed cardiac disease or families requiring follow up due to a death from this cause. NHS England is currently reviewing this service specification in line with the national service specification methods review process. The specification is available at the following link:

https://www.england.nhs.uk/wp-content/uploads/2017/11/cardiology-inherited-cardiac-conditions.pdf

In 2017, NHS England published a national service specification for inherited cardiac conditions (ICC) which defines the standards of care expected from organisations commissioned by NHS England. The specification sets the national minimum standards for the diagnosis, treatment, and outcome of patients with ICC.

NHS England is reviewing this service specification, working with a broad range of stakeholders, including National Health Service clinical experts, the Association of Inherited Cardiac Conditions, Cardiomyopathy UK, Heart Valve Voice, and the British Heart Foundation. This review considers the referral of ICC patients from primary care into ICC specialised services and considers how families of ICC patients are supported through the screening and identification process. The service specification review has also considered referrals directly from primary into secondary care, which would improve the timeliness of patient diagnosis.

Department ministers regularly have discussions with their colleagues and counterparts in Wales, Scotland, and Northern Ireland on matters of cross border interest.

In 2017, NHS England published a national service specification for inherited cardiac conditions (ICC) which defines the standards of care expected from organisations commissioned by NHS England. The specification sets the national minimum standards for the diagnosis, treatment, and outcome of patients with ICC.

NHS England is reviewing this service specification, working with a broad range of stakeholders, including National Health Service clinical experts, the Association of Inherited Cardiac Conditions, Cardiomyopathy UK, Heart Valve Voice, and the British Heart Foundation. This review considers the referral of ICC patients from primary care into ICC specialised services and considers how families of ICC patients are supported through the screening and identification process. The service specification review has also considered referrals directly from primary into secondary care, which would improve the timeliness of patient diagnosis.

Department ministers regularly have discussions with their colleagues and counterparts in Wales, Scotland, and Northern Ireland on matters of cross border interest.